1
/
of
1
Elabscience
SKU:PKSV030420
Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag)
Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag)
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag), a cutting-edge product designed to facilitate advanced research and development in the field of virology. This meticulously engineered recombinant protein offers a highly purified and reliable solution for studying the Spike Receptor Binding Domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag) showcases an innovative Q414E mutation, enabling researchers to explore the intricate interactions between the viral spike protein and its host receptor. This mutation, coupled with the incorporation of a His Tag, ensures enhanced stability and ease of purification, thereby streamlining experimental procedures.
With its exceptional purity and quality, this recombinant protein serves as an invaluable tool for investigating the molecular mechanisms underlying viral entry, host-pathogen interactions, and potential therapeutic interventions. Its application extends to a wide range of scientific endeavors, including vaccine development, drug discovery, and diagnostic assay design.
The Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag) is meticulously produced using state-of-the-art recombinant DNA technology, guaranteeing batch-to-batch consistency and reproducibility. Each vial is meticulously characterized, assuring researchers of its high bioactivity and reliability.
We understand the criticality of accurate and reliable research outcomes, which is why our product undergoes rigorous quality control measures to ensure its conformity to the highest industry standards. Our commitment to excellence is reflected in the purity, stability, and functionality of the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag), empowering researchers to make significant strides in combating the ongoing global health crisis.
In summary, the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag) stands as an indispensable asset for scientists and researchers seeking to unravel the complexities of SARS-CoV-2 infection. Its exceptional purity, stability, and bioactivity make it an ideal choice for a myriad of virological investigations, ultimately contributing to the advancement of scientific knowledge and the development of effective countermeasures against this formidable pathogen.
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag) showcases an innovative Q414E mutation, enabling researchers to explore the intricate interactions between the viral spike protein and its host receptor. This mutation, coupled with the incorporation of a His Tag, ensures enhanced stability and ease of purification, thereby streamlining experimental procedures.
With its exceptional purity and quality, this recombinant protein serves as an invaluable tool for investigating the molecular mechanisms underlying viral entry, host-pathogen interactions, and potential therapeutic interventions. Its application extends to a wide range of scientific endeavors, including vaccine development, drug discovery, and diagnostic assay design.
The Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag) is meticulously produced using state-of-the-art recombinant DNA technology, guaranteeing batch-to-batch consistency and reproducibility. Each vial is meticulously characterized, assuring researchers of its high bioactivity and reliability.
We understand the criticality of accurate and reliable research outcomes, which is why our product undergoes rigorous quality control measures to ensure its conformity to the highest industry standards. Our commitment to excellence is reflected in the purity, stability, and functionality of the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag), empowering researchers to make significant strides in combating the ongoing global health crisis.
In summary, the Recombinant SARS-CoV-2 Spike RBD(Q414E)(His Tag) stands as an indispensable asset for scientists and researchers seeking to unravel the complexities of SARS-CoV-2 infection. Its exceptional purity, stability, and bioactivity make it an ideal choice for a myriad of virological investigations, ultimately contributing to the advancement of scientific knowledge and the development of effective countermeasures against this formidable pathogen.
Share
